,46,47 The small-molecule CD4mcs will provide a novel class of inhibitors for drug development, these could be even more effective against EBOV than HIV, because sCD4 and CD4mcs are agonists for HIV infection, acting in trans to induce entry into cells that have low or negative CD4 levels.12 Here, SCD5 is linked to HIV infectious disease.